Home
Products

Recombinant Proteins
Bioactive Proteins Cytokines and Growth Factors Immune Checkpoint Proteins Enzyme Other Proteins

Antibodies
Primary antibodies Recombinant Monoclonal Antibodies Secondary antibodies Flow Cytometry (FACS) Antibodies Neutralizing Antibodies Isotype Controls Research Grade Biosimilars InVivo Plus InVivo Antibodies XtenNano®Nanobodies Bispecific Antibodies Antibodies against Small Molecules Tag Antibodies Anti-idiotype Antibodies

Assay Kits
ELISA Kits ADA Assay Kits PK Assay Kits Antibody Pairs
Research Area
Featured Products
Support
Information
- BioSpotlight
- Literature Highlights
About Us
Promotion Center

IL-2-producing TFH cells sustain Treg cell homeostasis and immune tolerance in the gut

Nature Immunology

Regulatory T (Treg) cells maintain immunological tolerance, but the cellular niches sustaining them across tissues are poorly defined. Work now identifies T follicular helper cells as a source of IL-2 that supports Treg cells in gut-associated lymphoid tissue and promotes intestinal immune homeostasis. Selective loss of IL-2 production by TFH cells results in intestinal inflammation and a fatal multiorgan inflammatory syndrome characterized by uncontrolled Teff cell expansion and dysregulated IgE production.

Related products

Catalog No.	Product Name	Description	Target
HS870026	Anti-Human PD-1 Reference Antibody (Pembrolizumab	Pembrolizumab (HS870026) is a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.	CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1, PD-1

Recombinant Proteins

Antibodies

Assay Kits

IL-2-producing TFH cells sustain Treg cell homeostasis and immune tolerance in the gut